2022 Hybrid Research Symposium Posters
The 2022 NETRF Hybrid Research Symposium poster session was held at the Boston meeting for presenters that attended in-person, however, all posters were viewable online through the virtual Symposium platform.
Please note that some presenters chose not to post their presentations online following the meeting and have been respectfully omitted here.
Search by Session or by Name:
Select Session
Name
Update on Clinical Evaluation of 3-[18F]fluoro-p-hydroxyphenethylguanidine ([18F]3F-PHPG) for Localization of Paraganglioma and Pheochromocytoma using Positron Emission Tomography (PET)
Presenter: Raffel
SV2A PET Imaging for Noninvasive Assessment of Neuroendocrine Differentiation in Neuroendocrine Tumors
Presenter: Hao
Survival differences of lung neuroendocrine tumors in California by sociodemographic, clinicopathologic, and treatment factors
Presenter: Mulvey
Proximity to Healthcare Providers, Bankruptcy, and Relationship Status within Neuroendocrine Cancer Patients
Presenter: Skill
PAK4/NAMPT inhibitor KPT-9274 synergizes with Sunitinib in Pancreatic Neuroendocrine Tumor Cellular Models
Presenter: Uddin
Monitoring the treatment of AR42J tumor-bearing mice with 225Ac-Crown-TATE
Presenter: Wasylishen
Image-guided delivery of temozolomide to SSTR2 expressing cells
Presenter: Aghaamiri
IgG4 related mesenteric fibrosis in small bowel neuroendocrine neoplasms
Presenter: Kaçmaz
Evaluation of DOTATATE-PET After Two Cycles of Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NETs)
Presenter: Duan
Endocrine-exocrine signaling drives pancreatic cancer progression
Presenter: Muzumdar
Effect of Epigenetic Treatment on SST2 Expression in Neuroendocrine Tumor Patients
Presenter: Refardt
A novel anti-SSTR bispecific T-cell engager (BiTE®)-like molecule for the treatment of neuroendocrine tumors
Presenter: Pelle
